<?xml version="1.0" encoding="UTF-8"?>
<ref id="B79-viruses-12-00862">
 <label>79.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Okamoto</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Matsuoka</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Takenaka</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Haredy</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Tanimoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gomi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ishikawa</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Akagi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Akashi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Okuno</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection</article-title>
  <source>Clin. Vaccine Immunol.</source>
  <year>2012</year>
  <volume>19</volume>
  <fpage>979</fpage>
  <lpage>990</lpage>
  <pub-id pub-id-type="doi">10.1128/CVI.00016-12</pub-id>
  <pub-id pub-id-type="pmid">22552600</pub-id>
 </element-citation>
</ref>
